Dana Goldman, PhD
Leonard D. Schaffer Director's Chair
Distinguished Professor of Public Policy, Pharmacy, Economics, and Gerontology

  dana.goldman@usc.edu
Dana Goldman is the Leonard D. Schaeffer Chair and Distinguished Professor of Pharmacy, Public Policy, and Economics at the University of Southern California. He is also a nonresident senior fellow at The Brookings Institution and research associate with the National Bureau for Economic Research. For the past 10 years, he has led USC’s Schaeffer Center for Health Policy and Economics, one of the nation’s premier health policy programs within the Price School of Public Policy and School of Pharmacy.

He is the author of approximately 300 articles and book chapters in medicine, health policy, economics, and statistics. Professor Goldman pioneered a “Netflix model” to improve access to prescription drugs and the value of reduced copayments for the chronically ill. He has served as a health policy advisor to the Congressional Budget Office, Covered California, Fred Hutchinson Cancer Institute, and National Institutes of Health. He is a founding editor of the Forum for Health Economics and Policy and serves on several editorial boards including Health Affairs and the American Journal of Managed Care. He is a former director of the International Society for Pharmacoeconomics and Outcomes Research and the American Society of Health Economists. Dr. Goldman's research and opinion pieces have appeared in the New York Times, Wall Street Journal, Washington Post, Stat, Forbes, Business Week, U.S. News & World Report, The Economist, NBC Nightly News, PBS NewsHour, CNN, NPR, and other media.

Professor Goldman is an elected member of the National Academy of Medicine and the National Academy of Social Insurance. In 2016, he was appointed a Distinguished Professor at the University of Southern California in honor of accomplishments bringing the University “special renown.” He received the MetLife Foundation Silver Scholar Award in honor of his research to value healthy aging and medical innovations; the Eugene Garfield Economic Impact Prize, recognizing outstanding work demonstrating how medical research impacts the economy; the National Institute for Health Care Management Research Foundation award for excellence in health policy; and the Alice S. Hersh New Investigator Award recognizing contributions of a young scholar to health services research.

Professor Goldman advises many companies in the life sciences industry. He was a co-founder of Precision Health Economics in 2006—a consultancy that provides analytic services to pharmaceutical, biological and health care companies—and currently serves as a scientific advisor. He also spent 15 years at the RAND Corporation, where he held the Distinguished Chair in Health Economics and served as director of its health economics program and the Bing Center.

Professor Goldman received his B.A. summa cum laude from Cornell University and a Ph.D. in Economics from Stanford University.    

At the Ellison Institute, Professor Goldman is one of 10 affiliate members. 

Research Focus

Health Economics
Health Policy & Management
Public Policy

Education

BA

PhD

Economics (Summa cum Laude), Cornell University- 1988 
Economics, Stanford University- 1994

Awards

  • Member, National Academy of Social Insurance- 2018
  • Inaugural Associate Member, Center for the Economics of Human Development- 2018
  • Associates Award for Creativity in Research, University of Southern California- 2017
  • Distinguished Professor, University of Southern California- 2016
  • Robert Biller Outstanding Faculty Award, Price School of Public Policy- 2015
  • USC Mellon Mentoring Award- 2012
  • MetLife Foundation Silver Scholar Award- 2011
  • Member, National Academy of Medicine- 2009
  • Eugene Garfield Economic Impact of Medical and Health Research Award-2009
  • Edwin E. Huddleson, Jr. Outstanding Teacher Award, RAND Graduate School-2006
  • Annual Research Award, National Institute for Health Care Management-2002
  • Alice S. Hersh New Investigator Award, AcademyHealth- 2002
  • Article of the Year, Association for Health Services Research-2000
  • Stanford University Fellowship in Health Care Research and Health Policy-1993
  • John M. Olin Fellowship for Research in Economic Policy-1992
  • Summa Cum Laude with Distinction in All Subjects, Cornell University-1988
  • Phi Beta Kappa, Cornell University-1988
  • National Merit Scholar-1984

Leadership

  • Leonard D. Schaeffer Director’s Chair and Distinguished Professor of Public Policy, Pharmacy, and Economics (Gerontology by courtesy)
  • University of Southern California, 2013-Present
  • ACADIA Pharmaceuticals Scientific Advisory Board, 2017-Present
  • Nonresident Senior Fellow, Economic Studies Program, Brookings Institution, 2017-Present
  • Fred Hutchinson Cancer Institute, HICOR Advisory Board (Chair), 2013-Present
  • Director, NIA Roybal Center for Health Policy Simulation, 2004-Present
  • Research Associate, National Bureau of Economic Research, 2002-Present

Selected Publications

Trish et al. “Who Pays in Medicare Part D? Giving Plans More Skin in the Game.” NEJM, forthcoming.

Goldman D, et al. "A New Model for Pricing Drugs of Uncertain Efficacy.” NEJM Catalyst, Published online December 13, 2018. 

Dzau V, Ginsburg G, Van Nuys K, Goldman D. “Aligning incentives to fulfil the promise of personalized medicine.” The Lancet, 385(9982):2015-2120, May 6, 2015.

Goldman D, Philipson T. “Five myths about cancer care in America.” Health Affairs, 33(10):1801-4, 2014.

Goldman D, Cutler D, Rowe J, et al. “Substantial Health and Economic Returns From Delayed Aging May Warrant a New Focus For Medical Research.” Health Affairs, 32(10):1698-1705, 2013.

Lakdawalla D, Sun E, Jena A, Reyes C, Goldman D, Philipson T. "An Economic Evaluation of the War on Cancer." Journal of Health Economics, 29(1):333-346, May 2010.

Goldman D, Joyce G, Zheng Y. "Prescription Drug Cost Sharing: Association With Medication and Medical Utilization and Spending and Health." JAMA, 298(1):61-69, 2007.

Goldman D, Joyce G, Escarce J, Pace J, Solomon M, Laouri M, Landsman P, Teutsch S. "Pharmacy Benefits and The Use Of Drugs By The Chronically-Ill.” JAMA, 291(19):2344-50, 2004.

Goldman D, Berry S, McCabe M, et al. “The Incremental Costs of NCI-Sponsored Clinical Trials.” JAMA, 289(22):2970-2977, 2003.

Goldman D, Smith J. “Can Patient Self-Management Help Explain the SES Health Gradient?” Proceedings of the National Academy of Sciences, 99(16):10929-10934, 2002.


Dana Goldman, PhD
Leonard D. Schaffer Director's Chair
Distinguished Professor of Public Policy, Pharmacy, Economics, and Gerontology

dana.goldman@usc.edu
Dana Goldman is the Leonard D. Schaeffer Chair and Distinguished Professor of Pharmacy, Public Policy, and Economics at the University of Southern California. He is also a nonresident senior fellow at The Brookings Institution and research associate with the National Bureau for Economic Research. For the past 10 years, he has led USC’s Schaeffer Center for Health Policy and Economics, one of the nation’s premier health policy programs within the Price School of Public Policy and School of Pharmacy.

He is the author of approximately 300 articles and book chapters in medicine, health policy, economics, and statistics. Professor Goldman pioneered a “Netflix model” to improve access to prescription drugs and the value of reduced copayments for the chronically ill. He has served as a health policy advisor to the Congressional Budget Office, Covered California, Fred Hutchinson Cancer Institute, and National Institutes of Health. He is a founding editor of the Forum for Health Economics and Policy and serves on several editorial boards including Health Affairs and the American Journal of Managed Care. He is a former director of the International Society for Pharmacoeconomics and Outcomes Research and the American Society of Health Economists. Dr. Goldman's research and opinion pieces have appeared in the New York Times, Wall Street Journal, Washington Post, Stat, Forbes, Business Week, U.S. News & World Report, The Economist, NBC Nightly News, PBS NewsHour, CNN, NPR, and other media.

Professor Goldman is an elected member of the National Academy of Medicine and the National Academy of Social Insurance. In 2016, he was appointed a Distinguished Professor at the University of Southern California in honor of accomplishments bringing the University “special renown.” He received the MetLife Foundation Silver Scholar Award in honor of his research to value healthy aging and medical innovations; the Eugene Garfield Economic Impact Prize, recognizing outstanding work demonstrating how medical research impacts the economy; the National Institute for Health Care Management Research Foundation award for excellence in health policy; and the Alice S. Hersh New Investigator Award recognizing contributions of a young scholar to health services research.

Professor Goldman advises many companies in the life sciences industry. He was a co-founder of Precision Health Economics in 2006—a consultancy that provides analytic services to pharmaceutical, biological and health care companies—and currently serves as a scientific advisor. He also spent 15 years at the RAND Corporation, where he held the Distinguished Chair in Health Economics and served as director of its health economics program and the Bing Center.

Professor Goldman received his B.A. summa cum laude from Cornell University and a Ph.D. in Economics from Stanford University.

At the Ellison Institute, Professor Goldman is one of 10 affiliate members. 

Research Focus

Health Economics
Health Policy & Management
Public Policy

Education

BA

Economics (Summa cum Laude), Cornell University- 1988 

PhD

Economics, Stanford University- 1994

Awards

  • Member, National Academy of Social Insurance- 2018
  • Inaugural Associate Member, Center for the Economics of Human Development- 2018
  • Associates Award for Creativity in Research, University of Southern California- 2017
  • Distinguished Professor, University of Southern California- 2016
  • Robert Biller Outstanding Faculty Award, Price School of Public Policy- 2015
  • USC Mellon Mentoring Award- 2012
  • MetLife Foundation Silver Scholar Award- 2011
  • Member, National Academy of Medicine- 2009
  • Eugene Garfield Economic Impact of Medical and Health Research Award-2009
  • Edwin E. Huddleson, Jr. Outstanding Teacher Award, RAND Graduate School-2006
  • Annual Research Award, National Institute for Health Care Management-2002
  • Alice S. Hersh New Investigator Award, AcademyHealth- 2002
  • Article of the Year, Association for Health Services Research-2000
  • Stanford University Fellowship in Health Care Research and Health Policy-1993
  • John M. Olin Fellowship for Research in Economic Policy-1992
  • Summa Cum Laude with Distinction in All Subjects, Cornell University-1988
  • Phi Beta Kappa, Cornell University-1988
  • National Merit Scholar-1984

Leadership 

  • Leonard D. Schaeffer Director’s Chair and Distinguished Professor of Public Policy, Pharmacy, and Economics (Gerontology by courtesy) University of Southern California, 2013-Present
  • ACADIA Pharmaceuticals Scientific Advisory Board, 2017-Present
  • Nonresident Senior Fellow, Economic Studies Program, Brookings Institution, 2017-Present
  • Fred Hutchinson Cancer Institute, HICOR Advisory Board (Chair), 2013-Present
  • Director, NIA Roybal Center for Health Policy Simulation, 2004-Present
  • Research Associate, National Bureau of Economic Research, 2002-Present

Selected Publications

Trish et al. “Who Pays in Medicare Part D? Giving Plans More Skin in the Game.” NEJM, forthcoming.

Goldman D, et al. "A New Model for Pricing Drugs of Uncertain Efficacy.” NEJM Catalyst, Published online December 13, 2018. 

Dzau V, Ginsburg G, Van Nuys K, Goldman D. “Aligning incentives to fulfil the promise of personalized medicine.” The Lancet, 385(9982):2015-2120, May 6, 2015.

Goldman D, Philipson T. “Five myths about cancer care in America.” Health Affairs, 33(10):1801-4, 2014.

Goldman D, Cutler D, Rowe J, et al. “Substantial Health and Economic Returns From Delayed Aging May Warrant a New Focus For Medical Research.” Health Affairs, 32(10):1698-1705, 2013.

Lakdawalla D, Sun E, Jena A, Reyes C, Goldman D, Philipson T. "An Economic Evaluation of the War on Cancer." Journal of Health Economics, 29(1):333-346, May 2010.

Goldman D, Joyce G, Zheng Y. "Prescription Drug Cost Sharing: Association With Medication and Medical Utilization and Spending and Health." JAMA, 298(1):61-69, 2007.

Goldman D, Joyce G, Escarce J, Pace J, Solomon M, Laouri M, Landsman P, Teutsch S. "Pharmacy Benefits and The Use Of Drugs By The Chronically-Ill.” JAMA, 291(19):2344-50, 2004.

Goldman D, Berry S, McCabe M, et al. “The Incremental Costs of NCI-Sponsored Clinical Trials.” JAMA, 289(22):2970-2977, 2003.

Goldman D, Smith J. “Can Patient Self-Management Help Explain the SES Health Gradient?” Proceedings of the National Academy of Sciences, 99(16):10929-10934, 2002.